Better Diagnosis and Treatment Lower Aneurysm Risk

Advances made in diagnosis and treatment over the past 30 years have reduced the risk of patients dying from aneurysmal subarachnoid haemorrhage (the bursting of a blood vessel on the surface of the brain), shows new research from the Netherlands published in the journal Lancet Neurology.

The study, an updated meta-analysis to assess changes in case fatality and morbidity and differences based on age, sex and region, shows that 8 in 100,000 people suffer from aneurysmal subarachnoid haemorrhage (SAH) each year. SAH is also responsible for between 5 and10 percent of incident stroke cases. The research also indicates that around a third of the patients die within 24 hours; over 25% of those who survive are left disabled.

Thanks to improvements in diagnosis like more advanced computed tomography (CT) and magnetic resonance imaging (MRI) techniques for detection of aneurysms, dedicated stroke units and treatments like endovascular coiling of burst aneurysms, physicians have been able to provide better prognoses for patients who are treatable.

However, it was still unclear whether these improved diagnoses, management strategies and stroke units have contributed to curbing the threat of SAH-related death or disability in the general population.

To get answers, Dr Dennis Nieuwkamp of the University Medical Centre Utrecht in the Netherlands and his colleagues conducted a meta-analysis of 33 studies involving 8,739 patients from 19 countries in 5 continents between 1973 and 2002. The results showed that the chance of dying from an SAH dropped from 51% to 35%, regardless of the fact that the average age of patients increased.

"Case fatality varied from 8.3% to 66.7% between studies and decreased 0.8% per year. The decrease was unchanged after adjustment for sex, but the decrease per year was 0.4% after adjustment for age," the study showed. "Case fatality was 11.8% lower in Japan than it was in Europe, the US, Australia and New Zealand." No other regional differences in case fatality were found.

According to the authors, disparities in how quickly patients were admitted to hospital for the early occlusion of the aneurysm could be the determining factor behind the regional differences. "In future, case fatality after SAH might decrease even more, owing to new diagnostic and therapeutic methods," the study reads. "This decrease will probably be limited to the substantial proportion of patients who die before reaching hospital or reach hospital in poor neurological condition."

"To decrease mortality from SAH, the incidence could be further reduced by prevention strategies. In future studies, meta-analysis of individual patient data would be an attractive method to get the best estimates of the rates of decline," the study concludes.

In an accompanying commentary, Drs Rustam Al-Shahi Salman and Cathie Sudlow of the University of Edinburgh in the UK said that while the reduction in case fatality after SAH is cause for optimism, two challenges remain: there is insufficient data on effectiveness of aneurysm treatment in the elderly and on how the results affect low-income to middle-income economies, as they were hardly represented in the meta-analysis.

For further information, please visit:

Copyright ©European Communities, 2009
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...